Institute of Computer Science, University of Tartu, Tartu, Estonia.
Software Technology and Applications Competence Center, Tartu, Estonia.
Int J Immunogenet. 2019 Apr;46(2):49-58. doi: 10.1111/iji.12413. Epub 2019 Jan 19.
Allele-specific analyses to understand frequency differences across populations, particularly populations not well studied, are important to help identify variants that may have a functional effect on disease mechanisms and phenotypic predisposition, facilitating new Genome-Wide Association Studies (GWAS). We aimed to compare the allele frequency of 11 asthma-associated and 16 liver disease-associated single nucleotide polymorphisms (SNPs) between the Estonian, HapMap and 1000 genome project populations. When comparing EGCUT with HapMap populations, the largest difference in allele frequencies was observed with the Maasai population in Kinyawa, Kenya, with 12 SNP variants reporting statistical significance. Similarly, when comparing EGCUT with 1000 genomes project populations, the largest difference in allele frequencies was observed with pooled African populations with 22 SNP variants reporting statistical significance. For 11 asthma-associated and 16 liver disease-associated SNPs, Estonians are genetically similar to other European populations but significantly different from African populations. Understanding differences in genetic architecture between ethnic populations is important to facilitate new GWAS targeted at underserved ethnic groups to enable novel genetic findings to aid the development of new therapies to reduce morbidity and mortality.
进行特定等位基因分析,以了解不同人群(尤其是研究较少的人群)之间的频率差异,这对于帮助识别可能对疾病机制和表型易感性具有功能影响的变异体很重要,有助于开展新的全基因组关联研究(GWAS)。我们旨在比较爱沙尼亚、HapMap 和 1000 基因组计划人群中 11 个哮喘相关和 16 个肝脏疾病相关单核苷酸多态性(SNP)的等位基因频率。在将 EGCUT 与 HapMap 人群进行比较时,肯尼亚 Kinyawa 的 Maasai 人群的等位基因频率差异最大,有 12 个 SNP 变体具有统计学意义。同样,在将 EGCUT 与 1000 基因组计划人群进行比较时,非洲混合人群的等位基因频率差异最大,有 22 个 SNP 变体具有统计学意义。对于 11 个哮喘相关和 16 个肝脏疾病相关 SNP,爱沙尼亚人在遗传上与其他欧洲人群相似,但与非洲人群有显著差异。了解不同种族群体之间遗传结构的差异对于促进针对服务不足的种族群体的新 GWAS 很重要,这有助于发现新的遗传发现,以帮助开发新的治疗方法,降低发病率和死亡率。